Tag Archives: Photo Immuno Therapy

8-Methoxypsoralene finally approved

Word Cloud 2 frei jpg

An important part of the Photopheresis therapy is connected with the use of a photosensitizer / photoactivator (8-MOP) in order to treat the collected white blood cells. The substance, in combination with the irradiation with UVA light, enables the therapy to become effective in the treatment of various diseases.

Recently the Austrian pharmaceutical manufacturer GL Pharma has received the official approval for the liquid form of 8-MOP (8-Methoxypsoralene) in Austria, which is now available.
For further general information and/or information concerning ordering please contact our customer service department (info@med-tech-solutions.com), which will be pleased to assist with any questions and provide you with all relevant contact information.